Related Experiment Video
Updated: Aug 12, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Physician versus patient use of AI for diabetes prevention: public perceptions and comfort levels
Gloria Maria Carmona Clavijo1, Paige Nong2, Sean Tan1
1TIERRA - Trust, Innovation & Ethics Research for Responsible AI, Department of Learning Health Science, Michigan Medicine, University of Michigan, Ann Arbor, MI, United States.
Background:
Type 2 diabetes is a major public health challenge that can often be prevented through lifestyle interventions. Artificial intelligence (AI) is increasingly used for risk prediction, behavioral coaching, and individualized prevention, offering scalability and low-intensity interventions. However, AI also raises ethical and regulatory concerns, especially for patient-facing tools. Limited evidence compares public comfort with physician use versus patient use for diabetes prevention.
Methods:
We analyzed data from a 2025 national survey conducted through the NORC AmeriSpeak Panel, a probability-based sample of 1,939 respondents. Participants evaluated two hypothetical AI use cases for diabetes prevention: Physician use of AI and patient use of AI-chatbot. Paired t-tests compared comfort across use cases. Weighted univariable and multivariable logistic regression models identified predictors of comfort.
Results:
Participants reported significantly greater comfort with physician use of AI than with patient use of an AI-chatbot for diabetes prevention (p < 0.001). Comfort across both cases was strongly associated with belief that AI benefits population health (patient-AI: OR = 3.67, p < 0.001; physician-AI: OR = 3.86, p < 0.001), trust in health system AI use (patient-AI: OR = 1.47, p < 0.001, physician-AI: OR = 1.72, p < 0.001), and physician confidence in AI reliability (patient-AI: OR = 1.31, P = 0.003; physician-AI: OR = 1.30, p < 0.001). Comfort with physician use of AI was lower among Black/African American participants than White participants (OR = 0.51, p < 0.001), while women reported lower comfort with patient use of AI compared than men (OR = 0.71, p = 0.032).
Conclusions:
Public comfort with AI for diabetes prevention appears higher when integrated with professional oversight. Trust in clinicians, health systems, and AI reliability may be central to acceptance. Differences across demographic groups highlight the importance of equity-focused, physician-led implementation, transparent communication, and inclusive trust-building strategies for ethical AI adoption.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes I: Introduction
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...